Otilimab, CAS [[1638332-55-4]]

Produktübersicht

• Artikelname: Otilimab, CAS [[1638332-55-4]]
• Artikelnummer: TGM-T77125
• Hersteller Artikelnummer: T77125
• Alternativnummer: TGM-T77125-1MG,TGM-T77125-5MG,TGM-T77125-10MG,TGM-T77125-25MG,TGM-T77125-50MG,TGM-T77125-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: GSK 3196165 , MOR103

Produktbeschreibung

Otilimab (GSK 3196165) is a humanized monoclonal antibody against granulocyt-macrophage colony-stimulating factor (GM-CSF). Otilimab has anti-inflammatory activity, regulates the biological function of GM-CSF by blocking the interaction between GM-CSF and its cell surface receptors, and can be used in studies to treat severe COVID-19 pneumonia.

Produkteigenschaften

• Reinheit: >95%
• CAS Nummer: [1638332-55-4]
• Target-Kategorie: CSF-1R|||c-Fms